Full article: Pharmacotherapy for Obesity: Recent Updates Beyond semaglutide and tirzepatide, where might we find the next GLP 1 based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and Tirzepatide vs. Semaglutide: Key Differences & Benefits Hubmed CagriSema in Clinical Trials: What Patients Should Know Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Cagrilintide Research Peptide Information Peptpedia